The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 28, 2023
Filed:
Dec. 06, 2021
Applicant:
Abivax, Paris, FR;
Inventors:
Sandrine Crabe, Saint-Gély-du-Fesc, FR;
Didier Scherrer, Castelnau le Lez, FR;
Hartmut Ehrlich, Paris, FR;
Philippe Pouletty, Paris, FR;
Assignee:
ABIVAX, Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/553 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/553 (2013.01); A61K 39/0011 (2013.01); A61K 39/001104 (2018.08); A61K 39/001106 (2018.08); A61K 39/001124 (2018.08); A61K 39/001129 (2018.08); A61K 39/001135 (2018.08); A61K 39/001174 (2018.08); A61K 39/39 (2013.01); A61K 39/39558 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); C07K 16/2818 (2013.01); A61K 45/06 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55572 (2013.01);
Abstract
An antitumor pharmaceutical combination includes (i) a compound ABX196 and (ii) at least one chemotherapeutic agent and/or at least one immunotherapeutic agent, for use in the treatment of cancer.